If your medication has a lower concentration, such as 2 mg/mL, a 2.4 mg dose would actually require 120 units, which would necessitate more than one full 100-unit syringe
adult with obesity received a GLP-1 prescription, the total cost would top $1.2 trillion annually
As GLP-1R agonists mediate their appetite-reducing effects within the central nervous system, the trafficking phenotype of exendin-phe1 could result in reduced brain penetration, mitigating against presumed advantageous effects on neuronal GLP-1R desensitization
Aim for a protein target of roughly 1.2 to 1.6 g/kg and pair that with resistance training at least twice a week to help preserve muscle
Circulation 91:11011106 McEniery CM, Yasmin WS, Maki-Petaja K, McDonnell B, Sharman JE, Retallick C, Franklin SS, Brown MJ, Lloyd RC, Cockcroft JR, Wilkinson IB (2005) Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults
Other medical reasons for pausing treatment include severe gastrointestinal adverse effects that don't improve with dose reduction or supportive measures, acute kidney injury related to dehydration from gastrointestinal side effects, severe hypoglycemia (particularly when combined with insulin or sulfonylureas), and worsening diabetic retinopathy